Facts & Facts about Johnson & Johnson
#1 in The Biggest BIG PHARMAs and Why They're Big series
In this series, The Biggest BIG PHARMAs and Why They're Big series, I’m going to be looking at the top Pharma companies by market cap and explore some of their history and biggest money making products.
Johnson & Johnson
Not only the biggest pharma company, but with a Market Cap of $428.38 Billion, JNJ is the 9th most valuable company in the world.
About Johnson & Johnson
They are headquartered in New Brunswick, New Jersey
J&J Employs 130,000 people in 60 countries
The CEO is Joaquin Duato.
Originally from Valencia.
Speaks Spanish, Italian and English
MBA from ESADE
Joined Janssen Pharmaceutica in 1989 in Spain and worked his way up the corporate ladder.
Here are some big, recognizable subsidiary names:
A little history
Johnson & Seabury was founded in 1873 by Robert Wood Johnson and George Seabury, primarily selling medicated plasters.
In 1886, Robert Wood joined his brothers James Wood and Edward Mead to create a line of sterile surgical dressings under the name Johnson & Johnson. They expanded into first aid kits.
In 1894, they began to produce Johnson’s Baby Powder, then maternity kits.
J&J went public in 1943. By that time, they had produced first aid, medical relief, masks and surgical products for many wars & disasters including WWI, the 1918 flu, the 1906 San Francisco earthquake and many others. They had earned a reputation as a very good employer, expanding during the great depression and promising to reserve jobs for those who fought in WWII.
1959 - J&J acquired McNeil Consumer Healthcare, a manufacturer of prescription drugs, including Tylenol. They followed this acquisition with Cilag in 1959, Janssen Pharmaceuticals (developer of ADHD and antipsychotic medicines) in 1961, DePuy Synthes (manufacturer of minimally invasive devices for strokes) in 1998, and Janssen Biotech in 1999, Ethicon in 2008, and many others.
Since 2010, acquisition activity added Crucell (vaccines), Coherex (for atrial fibrillation treatements), Abbot Medical Optics, Actelion, Intefra LifeSciences, Tear science, LifesScan and Momenta Pharamceuticals.
In 2020, J&J and its subsidiaries aided the covid response by ramping up Tylenol production, innovating on ventilator use by introducing a splitter, and developing its own single-shot vaccine, which partly due to a rare clotting disorder in six recipients, fell far behind rival Pfizer and Moderna vaccines. In April 2021, the vaccine had achieved $100 million in sales, less than 1% of J&J’s revenues
Major drugs/treatments
https://www.drugwatch.com/manufacturers/johnson-and-johnson/
Pharmaceuticals
Pharmaceutical sales amounted to $45.6 Billion in 2020.
Top drugs:
COVID-19 vaccine- Single dose vaccine for COVID-19
Stelara - Auto-immune treatment that can be used for Crohn’s disease, ulcerative colitis, plaque psoriasis & psoriatic arthritis
Darzalex- treatment for multiple myloma, a cancer that forms in plasma cells (a type of white blood cell)
Imbruvica- oral treatment for certain lymphomas
Tremfya- treatment for moderate to severe plaque psoriasis.
Erleada- treatment for prostate cancer
Uptravi - treatment for pulmonary arterial hypertension
Invega - treatment for schizophrenia
Opsumit - treatment for pulmonary arterial hypertension
Medical Devices
Medical Device Sales were $23 billion in 2020
Top Medical devices:
Hip Implants
Knee Implants
Spine Implants
Consumer Health
Consumer Health Sales were $14.1 billion in 2020
Top Consumer Health Products:
Tylenol - Over the counter pain reliever and fever reducer
Listerine - mouthwash
Band-aid - Line of adhesive bandages
Pepcid - Over the counter heartburn relief
Aveeno - Skin moisturizers, facial treatments, body washes, make up removers, etc.
Zyrtec - over the counter allergy relief
NEXT:
Eli Lilly
Roche
Pfizer
Novo Nordisk